Global Genetic Analysis Market Trends and Growth Analysis 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Genetic Analysis Market Over The Five-Year Period 2025–2029?

The genetic analysis market has seen swift growth in recent years. It is forecast to expand from $9.09 billion in 2024 to $10.29 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.2%. This historical expansion can be attributed to several factors, including the increasing occurrence of genetic and rare diseases, the growing use of genetic testing in oncology, a rising demand for personalized medicine, the necessity for early disease detection and prevention, and heightened awareness concerning hereditary diseases.

The genetic analysis market is poised for significant expansion in the coming years. Its size is forecast to reach $16.66 billion in 2029, growing at a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is attributed to a rise in newborn screening programs, increasing utilization in managing chronic conditions, an aging population, a heightened focus on pediatric genetic testing, and the growing prevalence of lifestyle-related diseases with genetic links. Prominent trends for this period include rapid advancements in next-generation sequencing technologies, the emergence of CRISPR and other gene editing tools, improved bioinformatics and data interpretation tools, the adoption of AI and machine learning in genomic data analysis, and the miniaturization of sequencing instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Genetic Analysis Industry?

The escalating incidence of cancer is anticipated to fuel the expansion of the genetic analysis market. Cancer is defined as a disease where specific body cells multiply uncontrollably and may spread to other regions. The rise in cancer cases is largely due to an aging population, as older individuals are more prone to accumulating genetic mutations and prolonged exposure to environmental and lifestyle risk factors contributing to cancer development. Genetic analysis proves beneficial for cancer by identifying the precise genetic mutations responsible for the illness, thereby enabling doctors to opt for targeted treatments that are both more effective and lead to fewer adverse effects. For instance, a report from the National Cancer Institute (NCI) in May 2025 indicated that nearly 20 million people worldwide were newly diagnosed with cancer in 2022, and approximately 9.7 million succumbed to it. Forecasts suggest that by 2050, the yearly number of new cancer cases could reach 33 million, with cancer-related deaths potentially increasing to 18.2 million. This increase in cancer cases is therefore a significant driver for the growth of the genetic analysis market.

Which Key Segments Fueling The Genetic Analysis Market?

The genetic analysis market covered in this report is segmented

1) By Product: Reagents And Kits, Instruments, Software

2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests

3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies

4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications

5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits

2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms

3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools

Which Key Trends Are Expected To Influence The Genetic Analysis Market In The Coming Years?

Companies operating in the genetic analysis market are primarily focused on developing advanced products, such as genetic testing solutions, to enable preventive measures or early detection. Genetic testing solutions involve examining an individual’s DNA to identify changes or variations in genes that might be linked to particular health conditions or inherited traits. For instance, in June 2023, Devyser, a Sweden-based company specializing in diagnostic kit development, launched Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions aimed at hereditary cancer. Devyser LynchFAP distinguishes itself by offering a complete solution for analyzing PMS2 and nine additional genes related to hereditary colorectal cancer, effectively resolving the complex task of differentiating PMS2 from its pseudogene PMS2CL. It is the first commercial kit specifically designed for precise analysis of the PMS2 gene. Devyser BRCA PALB2 allows for targeted identification of genetic variants in BRCA1, BRCA2, and PALB2, which are key genes associated with an increased risk of breast and ovarian cancer. Its user-friendly interface permits quick integration into lab workflows and supports DNA analysis from both blood and tumor samples within a single test.

Which Key Market Players Are Investing In Expansion And Innovation Of Genetic Analysis Market?

Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., and Genebase.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report

Which Region Is Projected To Lead The Genetic Analysis Market During The Forecast Period?

North America was the largest region in the genetic analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genetic Analysis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27295&type=smp

Browse Through More Reports Similar to the Global Genetic Analysis Market 2025, By The Business Research Company

Scanner Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

Scanner Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/scanner-software-global-market-report

Document Scanning Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/document-scanning-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795